The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (25 analysts) rates it buy, with a mean price target of $256.
Waste Management
WM · a US exchange · USD · Market cap $91.8B · 60,500 employees
Waste Management, Inc., through its subsidiaries, provides environmental solutions to residential, commercial, industrial, and municipal customers in the United States, Canada, Western Europe, and internationally.
FAIL · Does not pass the screenPrice as of 3 Nov 2026Daily close, not a live quote
Screened 2026-11-03 · the tape above runs as of 10:13 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price234.67 USD at the 3 Nov 2026 close
- Our value readFair vs our fair value, as of 3 Nov 2026
- Our regime readMarkup, as of 2 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.29)
- Last reviewed3 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $198.00 to $252.18, base estimate $219.29 (screen dated 2026-11-03).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning political selling, disclosed 2026-09-25
- Options put/call open interest 0.29, read 2026-11-02
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Waste Management holds its Markup at $234.67. The statistical read favours the buyers, held for 1 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 1 days |
| Price at the screen | $234.67 |
| Valuation | 30.30 trailing · 25.72 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.43 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 49.98% | Below 33% | Interest-bearing debt is 50.0% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 1.70% | Below 33% | Cash held in interest-bearing accounts and securities is 1.7% of assets, under the one-third limit. | Pass |
| Receivables | 7.93% | Below 49% | Money owed to the company is 7.9% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Waste Management's business is in a permissible area, but its interest-bearing debt is about 50% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-04. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when WM's ethical verdict changes
Today WM does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 3 Nov 2026: it trades above our $219.29 fair value estimate, moderate competitive moat, 6.30% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-03 screen. The gold marker is the market price at the same screen. The price runs 7.0% above the base estimate.
Third-party analyst targets: 25 covering, consensus Buy. The average target sits +10% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $219.29, with a range of $198.00 to $252.18, dated to the 2026-11-03 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it is worth knowing
A quality business: a moderate moat. At the screened price it sits 8% above our $219.29 fair value: priced for the quality, not a bargain.
| Forward P/E | 25.7xexpensive even after accounting for its growth |
| Trailing P/E | 30.3xa premium valuation |
| EPS, trailing | 7.62 |
| EPS, forward | 8.98 |
| Revenue growth | +6.3%slow but positive growth |
| Profit margin | 11.8%thin but positive margins |
| Return on equity | 31.7%an exceptional return on shareholder capital |
| Dividend yield | 159.00% |
| Debt to equity | 2.37heavy leverage: higher risk if revenue softens |
| Current ratio | 0.82below 1: short-term bills exceed liquid assets |
| Beta | 0.43barely tracks the market's swings |
| Short interest, float | 0.02% |
| 52-week range | 194.11 - 248.13 |
| Moat | MODERATE |
| Market cap | $91.8B |
| Employees | 60,500 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeWM trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (25 analysts) rates it buy, with a mean price target of $256. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (25 analysts) rates it buy, with a mean price target of $256. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (25 analysts) rates it buy, with a mean price target of $256. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (25 analysts) rates it buy, with a mean price target of $256. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (25 analysts) rates it buy, with a mean price target of $256. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (25 analysts) rates it buy, with a mean price target of $256. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (25 analysts) rates it buy, with a mean price target of $256. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 7.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (25 analysts) rates it buy, with a mean price target of $256. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (25 analysts) rates it buy, with a mean price target of $256.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Fiserv Q3 Earnings Beat Estimates, Revenues Decline Y/Y Yahoo Finance · 20h ago
- Gartner Q3 Earnings Beat Estimates, Revenues Move Up 2% Y/Y Yahoo Finance · 20h ago
- Is Waste Management a Buy After Its Latest Earnings Report? Yahoo Finance · 2d ago
- VEOEY vs. WM: Which Stock Is the Better Value Option? Yahoo Finance · 2d ago
- Sunday Lake Gold Corp. Appoints New Director Yahoo Finance · 2d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-20 | DALBY MARCEL | Officer | 2,257 | · | |
| 2026-05-20 | HEMMER TARA J | Chief Operating Officer | 2,544 | · | |
| 2026-05-15 | CHINN BRUCE E. | Director | 861 | $190,031 | |
| 2026-05-15 | GLUSKI ANDRES RICARDO | Director | 861 | $190,031 | |
| 2026-05-15 | BENE THOMAS L | Director | 861 | $190,031 | |
| 2026-05-15 | SYLVESTER MARYROSE T | Director | 861 | $190,031 | |
| 2026-05-15 | HOLT VICTORIA M | Director | 861 | $190,031 | |
| 2026-05-15 | MAZZARELLA KATHLEEN M. | Director | 1,314 | $290,013 | |
| 2026-05-15 | PLUMMER WILLIAM B | Director | 861 | $190,031 | |
| 2026-05-15 | MENKE SEAN EDWARD | Director | 861 | $190,031 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-25 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-09-11 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-09-11 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-09-11 | Ro Khanna | Democrat | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $213.19 | +5.2% | $0.95 | $1,056 | +5.6% |
| 2 months | $228.46 | -1.8% | $0.95 | $986 | -1.4% |
| 3 months | $236.64 | -5.2% | $1.89 | $956 | -4.4% |
| 6 months | $210.30 | +6.7% | $1.89 | $1,075 | +7.5% |
| 1 year | $230.30 | -2.6% | $3.54 | $989 | -1.1% |
| 2 years | $195.74 | +14.6% | $6.69 | $1,180 | +18.0% |
| 3 years | $155.38 | +44.4% | $9.59 | $1,505 | +50.5% |
| 5 years | $129.39 | +73.3% | $14.74 | $1,847 | +84.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever WM does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.